These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 21224499)

  • 1. Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats.
    Dworzanski T; Celinski K; Korolczuk A; Slomka M; Radej S; Czechowska G; Madro A; Cichoz-Lach H
    J Physiol Pharmacol; 2010 Dec; 61(6):683-93. PubMed ID: 21224499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
    Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R
    J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; Alarcón De La Lastra C
    Biochem Pharmacol; 2005 Jun; 69(12):1733-44. PubMed ID: 15876425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge.
    Liu Y; Shi J; Lu J; Meng G; Zhu H; Hou Y; Yin Y; Zhao S; Ding B
    Innate Immun; 2009 Jun; 15(3):169-78. PubMed ID: 19474210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
    Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.
    Ramakers JD; Verstege MI; Thuijls G; Te Velde AA; Mensink RP; Plat J
    J Clin Immunol; 2007 May; 27(3):275-83. PubMed ID: 17510806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
    Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
    Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated and inactivated PPARs-γ modulate experimentally induced colitis in rats.
    Celinski K; Dworzanski T; Korolczuk A; Slomka M; Radej S; Cichoz-Lach H; Madro A
    Med Sci Monit; 2011 Apr; 17(4):BR116-24. PubMed ID: 21455100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Liu D; Zeng BX; Zhang SH; Yao SL
    Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the anti-inflammatory and therapeutic actions of PPAR-gamma agonists rosiglitazone and troglitazone in experimental colitis.
    Celinski K; Dworzanski T; Fornal R; Korolczuk A; Madro A; Slomka M
    J Physiol Pharmacol; 2012 Dec; 63(6):631-40. PubMed ID: 23388479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of anti-inflammatory properties of peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone in prophylactic treatment of experimental colitis.
    Celinski K; Dworzanski T; Fornal R; Korolczuk A; Madro A; Brzozowski T; Slomka M
    J Physiol Pharmacol; 2013 Oct; 64(5):587-95. PubMed ID: 24304573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
    Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
    Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
    Yin Y; Hou G; Li ER; Wang QY; Kang J
    Respirology; 2013 Nov; 18 Suppl 3():30-9. PubMed ID: 24188201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation.
    Villegas I; Martín AR; Toma W; de la Lastra CA
    Eur J Pharmacol; 2004 Nov; 505(1-3):195-203. PubMed ID: 15556153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
    Wu Y; Zhao XD; Zhuang Z; Xue YJ; Cheng HL; Yin HX; Shi JX
    Brain Res; 2010 Mar; 1322():102-8. PubMed ID: 20132800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Fulia F; Cuzzocrea E; Di Rosa M; Caputi AP; Thiemermann C
    Crit Care Med; 2004 Feb; 32(2):457-66. PubMed ID: 14758164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone, a peroxisome proliferator-activated receptor gamma activator, ameliorates experimental autoimmune myocarditis by modulating Th1/Th2 balance.
    Hasegawa H; Takano H; Zou Y; Qin Y; Hizukuri K; Odaka K; Toyozaki T; Komuro I
    J Mol Cell Cardiol; 2005 Feb; 38(2):257-65. PubMed ID: 15698832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor-gamma in pioglitazone mediated chronic gastric ulcer healing in rats.
    Lahiri S; Sen T; Palit G
    Eur J Pharmacol; 2009 May; 609(1-3):118-25. PubMed ID: 19281808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.